|
|
Volumn 28, Issue 1-2, 2008, Pages 21-26
|
|
New anticoagulants;Neue antikoagulanzien
a
|
|
Author keywords
Clinical studies; Factor Xa inhibitor; Thrombin inhibitor; Venous thromboembolism
|
|
Indexed keywords
2 [4 [(1 ACETIMIDOYL 3 PYRROLIDINYL)OXY]PHENYL] 3 (7 AMIDINO 2 NAPHTHYL)PROPIONIC ACID;
ACTIVATED PROTEIN C;
ANTICOAGULANT AGENT;
ANTIVITAMIN K;
APIXABAN;
ARGATROBAN;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
DABIGATRAN;
DABIGATRAN ETEXILATE;
DESULFATOHIRUDIN;
DROTRECOGIN;
ENOXAPARIN;
FONDAPARINUX;
HEPARIN;
HIRULOG;
IDRAPARINUX;
LEPIRUDIN;
LOW MOLECULAR WEIGHT HEPARIN;
MELAGATRAN;
N [2 [4 (1 METHYL 4 PIPERIDINYL) 1 PIPERAZINYL] 2 OXO 1 PHENYLETHYL] 1H INDOLE 6 CARBOXAMIDE;
PLACEBO;
PRADAXA;
RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR;
RIVAROXABAN;
THROMBIN INHIBITOR;
UNCLASSIFIED DRUG;
XIMELAGATRAN;
ACUTE CORONARY SYNDROME;
BLOOD CLOTTING;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG APPROVAL;
DRUG TARGETING;
DRUG WITHDRAWAL;
HEART ATRIUM FIBRILLATION;
HUMAN;
STROKE;
TREATMENT INDICATION;
VENOUS THROMBOEMBOLISM;
|
|
EID: 40349111438
PISSN: 07209355
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0037-1616916 Document Type: Conference Paper |
|
Times cited : (14)
|
|
References (39)
|
